Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study (Q46494607)
Jump to navigation
Jump to search
scientific article published in July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study |
scientific article published in July 2008 |
Statements
1 reference
Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study (English)
1 reference
Russell J Schilder
1 reference
Michael W Sill
1 reference
Roger B Lee
1 reference
Mary K Senterman
1 reference
Andres J Klein-Szanto
1 reference
Zoe Miner
1 reference
Barbara C Vanderhyden
1 reference
1 July 2008
1 reference
26
1 reference
20
1 reference
3418-3425
1 reference